Ottobock is slimming down by selling its wheelchair business.
The prosthesis manufacturer has concluded an agreement to sell the “Human Mobility” division to the international medical technology company DHCare, the SDAX company announced on Friday in Duderstadt. The deal is expected to close in the second half of 2026. Financial details of the sale were not disclosed. With the sale, the company wants to concentrate on its core business with prostheses. The Ottobock share was recently quoted 2.4 percent higher at 51.50 euros via XETRA.
/err/jha/
DUDERSTADT (dpa-AFX)
Selected leverage products on Ottobock
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Ottobock
The leverage must be between 2 and 20
Risk warning: Suffer on average 7 out of 10 retail investors Losses when trading with turbo certificates. Turbo certificates are high-risk products and not suitable for long-term investment strategies. Risk warning: Suffer on average 7 out of 10 retail investors Losses when trading with turbo certificates. Turbo certificates are high-risk products and not suitable for long-term investment strategies.
Advertising
Image sources: Roman Babakin / Shutterstock.com, Wirestock Creators / Shutterstock.com